Audits Set to Resume August 3, Updated FAQs On COVID-19 Provider Burden Relief

Published in Women's Health on July 20, 2020

August 3 seems to be an important date for CMS. On August 3, the DME MACs, SMRC, and RAC will be able to resume audit activity. 

Here is a recent update from the “Coronavirus Disease 2019 (COVID-19) Provider Burden Relief Frequently Asked Questions (FAQs)” that are attached as well.  Prior Authorizations will resume as business as usual for PMDs and Group 2 Support Surfaces.  Also, the lower limb prosthetics (6 codes) will begin prior authorization activity with a phased approach with Phase 1 starting Sept 1, 2020.

If you have questions about these updates, contact Ronda Buhrmester.

Q. Is CMS suspending most Medicare Fee-For-Service (FFS) medical review during the Public Health Emergency (PHE) for the COVID-19 pandemic?

A. On March 30th, CMS suspended most Medicare Fee-For-Service (FFS) medical review because of the COVID-19 pandemic. This included pre-payment medical reviews conducted by Medicare Administrative Contractors (MACs) under the Targeted Probe and Educate program, and post-payment reviews conducted by the MACs, Supplemental Medical Review Contractor (SMRC) reviews and Recovery Audit Contractor (RAC). As states reopen and given the importance of medical review activities to CMS’ program integrity efforts, CMS expects to discontinue exercising enforcement discretion beginning on August 3, 2020, regardless of the status of the public health emergency. If selected for review, providers should discuss with their contractor any COVID-19-related hardships they are experiencing that could affect audit response timeliness. CMS notes that all reviews will be conducted in accordance with statutory and regulatory provisions, as well as related billing and coding requirements. Waivers and flexibilities in place at the time of the dates of service of any claims potentially selected for review will also be applied

Q. When is CMS resuming the Prior Authorization Program for DMEPOS items?

A. Given the importance of medical review activities to CMS’ program integrity efforts, CMS expects to discontinue exercising enforcement discretion beginning on August 3, 2020, regardless of the status of the public health emergency. CMS will resume full operations for the prior authorization program for certain DMEPOS items. For Power Mobility Devices and Pressure Reducing Support Surfaces that require prior authorization as a condition of payment, claims with an initial date of service on or after August 3, 2020, must be associated with an affirmative prior authorization decision to be eligible for payment. For an updated list of items that require prior authorization please visit: https://www.cms.gov/Research-Statistics-Data-and-Systems/Monitoring-Programs/Medicare-FFS-Compliance-Programs/DMEPOS/Downloads/DMEPOS_PA_Required-Prior-Authorization-List.pdf 


TAGS

  1. covid-19
  2. essentially women
  3. women's health

From Our Experts

Connections, Community, and Innovation: The Focus at Heartland Conference's Networking Experience thumbnail Connections, Community, and Innovation: The Focus at Heartland Conference's Networking Experience The VGM Heartland Conference stands out as a premier event, celebrated for its exceptional networking opportunities and memorable social events. Understanding Compression Therapy: A Vital Approach for Wound Management for Venous Insufficiency and Lymphedema thumbnail Understanding Compression Therapy: A Vital Approach for Wound Management for Venous Insufficiency and Lymphedema There are various kinds of compression that can be used to treat wounds in the wound care field. DME: A Growing Industry Shaped by Changing Healthcare Landscape thumbnail DME: A Growing Industry Shaped by Changing Healthcare Landscape There is a tremendous reason for optimism in the durable medical equipment (DME) provider community today. It's a market that's poised to experience significant growth in the coming decade, driven by a myriad of compounding factors. Exploring Focus at Heartland Conference 2024: What's on the Agenda? thumbnail Exploring Focus at Heartland Conference 2024: What's on the Agenda? At Focus at Heartland 2024, taking place June 10-12 in Waterloo, IA, prepare for unparalleled educational sessions with our diverse array of specialized tracks that can help you get insights for your women's health business. [Important Announcement] Updated 855S Application Released thumbnail [Important Announcement] Updated 855S Application Released For those businesses that have been patiently waiting for the 855S application to be updated with the Lymphedema Compression Treatment items as a product being offered, it is finally here. 2024 Audit and Compliance Forecast thumbnail 2024 Audit and Compliance Forecast President of The van Halem Group, Wayne van Halem, provides his insight on what suppliers should expect to see from an audit and compliance perspective in 2024. Humanizing the Future: Balancing AI Innovation and Personal Touch in HME Marketing thumbnail Humanizing the Future: Balancing AI Innovation and Personal Touch in HME Marketing The growth of the HME industry, fueled by the increasing needs of our aging population and the surge in chronic diseases, is creating new horizons. Registration Opens for Focus at Heartland 2024 thumbnail Registration Opens for Focus at Heartland 2024 Registration for the Focus at Heartland Conference is now open. We are looking forward to Essentially Women and VGM Heartland Conference joining forces to bring the women's health community together at this exciting event taking place in Waterloo, Iowa, June 10-12.